Prepulse inhibition of the startle response in risperidone-treated patients: Comparison with typical antipsychotics

Schizophrenia Research

Volumn 55, Issue 1-2, 2002, Pages 139-146

  Kumari, Veena ^a   Soni, William ^a   Sharma, Tonmoy ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antipsychotics; Prepulse inhibition; Risperidone; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; ORPHENADRINE; PROCYCLIDINE; RISPERIDONE;

ACCLIMATIZATION; ADULT; ARTICLE; AUDITORY RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAPHY; EYELID REFLEX; HUMAN; MALE; PREPULSE INHIBITION; PRIORITY JOURNAL; SAMPLE SIZE; SCHIZOIDISM; SCHIZOPHRENIA; STARTLE REFLEX; SYMPTOM;

ACOUSTIC STIMULATION; ADULT; ANTIPSYCHOTIC AGENTS; AROUSAL; ATTENTION; AUDITORY PERCEPTION; HUMANS; MALE; MIDDLE AGED; NEURAL INHIBITION; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STARTLE REACTION;

EID: 0036568988     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00276-6     Document Type: Article

References (51)

1. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man
2. Antagonism of phenclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine
3. Clozapine antagonises phencyclidine induced deficits in sensorimotor gating of the startle response
4. Information processing and attention dysfunctions in schizophrenia
5. Sensorimotor gating and schizophrenia
6. Prestimulus effects on human startle reflex in normals and schizophrenics
7. Gating and habituation of the startle reflex in schizophrenic patients
8. Symptoms correlates of prepulse inhibition deficits in male schizophrenic patients
9. Perspectives on the role of serotonergic mechanism in the pharmacology of schizophrenia
10. Wisconsin card sorting deficits and diminished sensorimotor gating in a discrete subgroup of subjects
11. The current status of the dopamine hypothesis of schizophrenia
12. Cognitive, clinical, and neuropsychological implications of startle modulatio
13. Switching from depot antipsychotics to risperidone: Results of a study of chronic schizophrenia
14. Sensory gating in rats: Lack of correlation between auditory evoked potential gating and prepulse inhibition
15. Gender differences in age at onset of schizophrenia
16. Startle response models of sensorimotor gating and habituation deficits in schizophrenia
17. The more or less startling effects of weak prestimuli
18. What are the functional consequences of neurocognitive deficits in schizophrenia?
19. Startle gating deficit occurs across prepulse intensities in schizophrenic patients
20. Prepulse inhibition in medicated and unmedicated patients
21. Reflex modification in the domain of startle: 1. Some empirical findings and their interpretations for how the nervous system processes sensory input
22. Differences in frontal cortical activation by a working memory task following substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia
23. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex
24. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis
25. Risperidone and olanzapine: Optimal dosing for efficacy and tolerability in patients with schizophrenia
26. The positive and negative syndrome scale
27. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats
28. Failure of haloperidol to block the effects of phencyclidine and dizocipline-induced disruption of prepulse inhibition
29. Age at onset in schizophrenia: A familial perspective
30. Effects of single oral administrations of haloperidol and D-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers
31. Normalization of information processing deficits in schizophrenia with clozapine
32. Prepulse inhibition of the startle response in men with schizophrenia: Effects of age of onset of illness, symptoms, and medication
33. Effects of procyclidine on prepulse inhibition of the acoustic startle response in healthy human volunteers
34. A combined analysis of double-blind studies with risperidone vs. placebo and other antipsychotic agents: Factors associated with extra-pyramidal symptoms
35. Dopaminergic stimulation disrupts sensorimotor gating in the rat
36. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
37. Information-processing deficits and thought disorder in Schizophrenia
38. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients
39. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
40. Concurrent measurements of acoustic startle and auditory P50 evoked potential measures of sensory stimulation
41. The cognitive effects of conventional and atypical antipsychotics in schizophrenia
42. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia
43. Men are more inhibited than women by weak prepulses
44. The neural substrates of sensorimotor gating of the startle reflex: A review of recent findings and their implications
45. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients
46. Seroquel restores sensorimotor gating in phencycldine-treated rats
47. Changes in sensorimotor inhibition across the menstrual cycle: Implications for neuropsychiatric disorders
48. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
49. P50 suppression in recent-onset schizophrenia: Clinical correlates and risperidone effects
50. Disruption of prepulse inhibition following N-methyl-D-aspartete infusion into the ventral hippocampuss is antagonized by clozapine but not by haloperidol: A possible model for screening of atypical antipsychotics